BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/3/2016 11:05:00 AM | Browse: 1060 | Download: 2152
 |
Received |
|
2015-08-02 12:43 |
|
Peer-Review Started |
|
2015-08-03 11:45 |
|
To Make the First Decision |
|
2015-09-14 17:40 |
|
Return for Revision |
|
2015-09-15 14:30 |
|
Revised |
|
2015-10-24 03:40 |
|
Second Decision |
|
2015-11-23 18:00 |
|
Accepted by Journal Editor-in-Chief |
|
2015-11-23 18:35 |
|
Accepted by Company Editor-in-Chief |
|
2015-12-04 16:19 |
|
Articles in Press |
|
2015-12-04 16:19 |
 |
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2016-02-29 09:24 |
|
Publish the Manuscript Online |
|
2016-03-03 11:05 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Non-initiation of hepatitis C virus antiviral therapy in patients with human immunodeficiency virus/hepatitis C virus co-infection
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Christine U Oramasionwu, Angela DM Kashuba, Sonia Napravnik, David A Wohl, Lu Mao and Adaora A Adimora |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| University of North Carolina at Chapel Hill Center for AIDS Research an NIH |
P30 AI50410(to Dr. Oramasionwu) |
| NIH Loan Repayment Program (LRP) through the National Institute on Minority Health and Health Disparities |
L60 MD003770(to Dr. Oramasionwu) |
|
| Corresponding Author |
Christine U Oramasionwu, PharmD, PhD, Assistant Professor, UNC Eshelman School of Pharmacy, University of North Carolina, Kerr Hall 2215, Chapel Hill, NC 27599, United States. oramsc@unc.edu
|
| Key Words |
Human immunodeficiency virus; Hepatitis C virus; Co-infection; Antiviral therapy; Race |
| Core Tip |
Historically, hepatitis C virus (HCV) treat-ment rates have been low in patients with human immunodeficiency virus (HIV) co-infection, especially for African-American patients. Identifying the reasons for treatment non-initiation may help improve treatment rates among racially and ethnic minorities. In our study of patients with HIV/HCV coinfection, non-modifiable medical reasons, potentially modifiable medical reasons, and non-medical reasons for non-treatment were common among all patients, regardless of their race/ethnicity. There is a need to recognize and overcome potential treatment barriers in order to improve HCV treatment uptake in this patient population.
|
| Publish Date |
2016-03-03 11:05 |
| Citation |
Oramasionwu CU, Kashuba ADM, Napravnik S, Wohl DA, Mao L, Adimora AA. Non-initiation of hepatitis C virus antiviral therapy in patients with human immunodeficiency virus/hepatitis C virus co-infection. World J Hepatol 2016; 8(7): 368-375 |
| URL |
http://www.wjgnet.com/1948-5182/full/v8/i7/368.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v8.i7.368 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
